Retinal diseases are putting more than 300 million people around the world at risk of losing their sight. Once patients lose their site, there is currently no way to get it back, but now scientists ...

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease gene therapy. The candidate improved the structure and function of the ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Until about 20 years ago, people in the advanced stages of age-related macular degeneration (AMD) were almost certain to lose their central vision. Without the ability to see faces, read or drive, ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

(BPT) - If you have diabetes, you're intimately aware that building an experienced care team is key to protecting your health. From establishing care with a knowledgeable primary care physician to ...